These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 3916513)
21. Induction therapy with cyclosporine without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients. Jazzar A; Fagiuoli S; Sisson S; Zuhdi N; Cooper DK Clin Transplant; 1995 Aug; 9(4):334-9. PubMed ID: 7579743 [TBL] [Abstract][Full Text] [Related]
22. Continuous renal replacement therapy after heart transplantation. Stevens LM; El-Hamamsy I; Leblanc M; Perrault LP; Pellerin M; Bouchard D; Carrier M; Can J Cardiol; 2004 May; 20(6):619-23. PubMed ID: 15152292 [TBL] [Abstract][Full Text] [Related]
23. Conversion from cyclosporine to azathioprine following heart transplantation. McGiffin DC; Kirklin JK; McVay RF; Logic JR; Edwards ME; Diethelm AG J Heart Transplant; 1986; 5(2):99-104. PubMed ID: 3302165 [TBL] [Abstract][Full Text] [Related]
24. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection. Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569 [TBL] [Abstract][Full Text] [Related]
25. Avoidance of perioperative renal toxicity by a modified immunosuppression protocol. Kormos RL; Trento A; Hardesty RL; Griffith BP; Thompson M; Bahnson HT Transplant Proc; 1987 Feb; 19(1 Pt 3):2525-6. PubMed ID: 3274555 [No Abstract] [Full Text] [Related]
26. Outcome of cadaveric renal transplantation by induction treatment in the cyclosporine era. Hariharan S; Alexander JW; Schroeder TJ; First MR Clin Transplant; 1996 Apr; 10(2):186-90. PubMed ID: 8664516 [TBL] [Abstract][Full Text] [Related]
27. Does central nervous system toxicity occur in transplant patients with hypocholesterolemia receiving cyclosporine? Cooper DK; Novitzky D; Davis L; Huff JE; Parker D; Schlesinger R; Sholer C; Zuhdi N J Heart Transplant; 1989; 8(3):221-4. PubMed ID: 2661772 [TBL] [Abstract][Full Text] [Related]
28. Immunosuppression induction with daclizumab and antithymocyte globulin in cardiac transplantation: clinical experience with 8 cases. Huang XS; Chen DZ; Chen LW; Li ZQ; Liao CX Di Yi Jun Yi Da Xue Xue Bao; 2004 Feb; 24(2):126-8. PubMed ID: 14965807 [TBL] [Abstract][Full Text] [Related]
29. Powerful but limited immunosuppression for cardiac transplantation with cyclosporins and low-dose steroid. Griffith BP; Hardesty RL; Bahnson HT J Thorac Cardiovasc Surg; 1984 Jan; 87(1):35-42. PubMed ID: 6361393 [TBL] [Abstract][Full Text] [Related]
30. Effect of pentoxifylline on renal toxicity of cyclosporine: results of a clinical trial after heart transplantation. Carrier M; Pelletier GB; White M; Bois D; Pelletier LC J Heart Lung Transplant; 1996 Dec; 15(12):1179-83. PubMed ID: 8981202 [TBL] [Abstract][Full Text] [Related]
31. Immunosuppression in live-related donor renal transplantation. Iman A; Rao M; Juneja R; Jacob CK Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322 [TBL] [Abstract][Full Text] [Related]
32. Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression. Miller JT; Collins CD; Stuckey LJ; Luan FL; Englesbe MJ; Magee JC; Park JM Pharmacotherapy; 2009 Oct; 29(10):1166-74. PubMed ID: 19792990 [TBL] [Abstract][Full Text] [Related]
33. The impact of renal failure on survival following cardiac transplantation. Sezgin A; Akay TH; Gültekin B; Ozkan S; Ozdemir N; Aşlamaci S Transplant Proc; 2007 May; 39(4):1247-9. PubMed ID: 17524945 [TBL] [Abstract][Full Text] [Related]
34. The influence of acute preoperative pulmonary infarction on the results of heart transplantation. Young JN; Yazbeck J; Esposito G; Mankad P; Townsend E; Yacoub M J Heart Transplant; 1986; 5(1):20-2. PubMed ID: 3302155 [TBL] [Abstract][Full Text] [Related]